TScan Therapeutics, Inc.
TCRX
$0.97
$0.1315.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 128.06M | 152.41M | 184.45M | 218.05M | 251.69M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.71M | 4.80M | 3.71M | 3.09M | 3.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 132.77M | 157.21M | 188.17M | 221.13M | 254.84M |
|
|
|||||
| Total Current Assets | 132.77M | 157.21M | 188.17M | 221.13M | 254.84M |
| Net Property, Plant & Equipment | 64.13M | 66.45M | 68.74M | 70.62M | 71.09M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.10M | 5.13M | 5.32M | 6.81M | 6.79M |
| Total Assets | 201.99M | 228.79M | 262.23M | 298.56M | 332.71M |
|
|
|||||
| Total Accounts Payable | 2.30M | 1.24M | 6.35M | 4.54M | 4.97M |
| Total Accrued Expenses | 8.40M | 7.47M | 10.58M | 12.61M | 9.41M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.44M | 7.17M | 6.90M | 6.29M | 4.97M |
| Total Finance Division Other Current Liabilities | 1.83M | 2.82M | 5.38M | 7.89M | 10.47M |
| Total Other Current Liabilities | 1.83M | 2.82M | 5.38M | 7.89M | 10.47M |
| Total Current Liabilities | 19.97M | 18.70M | 29.21M | 31.32M | 29.82M |
|
|
|||||
| Total Current Liabilities | 19.97M | 18.70M | 29.21M | 31.32M | 29.82M |
| Long-Term Debt | 32.65M | 32.53M | 32.41M | 32.30M | 32.18M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 52.45M | 54.44M | 56.30M | 58.12M | 59.88M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 278.00K | 113.00K | 625.00K |
| Total Liabilities | 105.07M | 105.67M | 118.20M | 121.85M | 122.51M |
|
|
|||||
| Common Stock & APIC | 630.45M | 627.99M | 625.90M | 622.89M | 619.43M |
| Retained Earnings | -533.53M | -504.86M | -481.89M | -446.18M | -409.22M |
| Treasury Stock & Other | -- | -- | 2.00K | -4.00K | -4.00K |
| Total Common Equity | 96.92M | 123.12M | 144.02M | 176.71M | 210.20M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 96.92M | 123.12M | 144.02M | 176.71M | 210.20M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 96.92M | 123.12M | 144.02M | 176.71M | 210.20M |
|
|
|||||